{"ticker": {"uuid": "870b12bb-14ca-46b9-8c67-2d5e14cf062b", "symbol": "301096", "name": "Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.", "exchange": "SHZ", "country": "CN", "sector": "Healthcare", "industry": "Drug Manufacturers - General"}, "articles": [{"title": "Price to earnings forward of Hangzhou Bio-Sincerity Pharma-Tech Co., Ltd. Class A \u2013 SZSE:301096", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxPTGx0WjljMnlHVDd3ZFpGS1lyMFV2RkZfcW5wcUpuYXB0MnBveFZPS18xaFVvdXVQR3A2VWNMalkyS1c2NmhaUlNfMkhrZm1CcWRtRjE2SDZyVnlrLVkya3E3VTJKYmxGWXhibmxRREFpdTdEQzFwUE1CdDljZGp1UzRyNHBfR0NOZjRySEp2WU1SYkVQS0duVkw5Z0Rla01KdkE?oc=5", "source_name": "TradingView", "published_at": "2026-07-12T04:09:59+00:00", "published_display": "12 Jul 2026 04:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hangzhou Bio Sincerity Pharma-Tech identifies new exportin-1 receptor antagonists", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxQdmJNQUZ0SmZDMzFXdTBxcjAyZUxRMDRCZzd5WHlGYVdnR0NnUVBBcnJTZUptbm9jSWdJWG14YWUyaVFHM0tOc3dyYXFPU1g1YllpUWhlUDV1QThBdkRTYkdEcWQ2a09RYzNNdDZTeDZzRXVSYlk3QTRaa1hCR256bm5IWVY3c2VUbi02UXZNMFUxajlCMEFxamNYLU9zWkk1Wk1IcVNHRjJabXFkdE5NcjJwLWtyM2xGNS1vN25SRQ?oc=5", "source_name": "BioWorld News", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Price to earnings forward of Hangzhou Bio-Sincerity Pharma-Tech Co., Ltd. Class A \u2013 SZSE:301096", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxPTGx0WjljMnlHVDd3ZFpGS1lyMFV2RkZfcW5wcUpuYXB0MnBveFZPS18xaFVvdXVQR3A2VWNMalkyS1c2NmhaUlNfMkhrZm1CcWRtRjE2SDZyVnlrLVkya3E3VTJKYmxGWXhibmxRREFpdTdEQzFwUE1CdDljZGp1UzRyNHBfR0NOZjRySEp2WU1SYkVQS0duVkw5Z0Rla01KdkE?oc=5", "source_name": "TradingView", "published_at": "2026-07-12T04:09:59+00:00", "published_display": "12 Jul 2026 04:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hangzhou Bio Sincerity Pharma-Tech identifies new exportin-1 receptor antagonists", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxQdmJNQUZ0SmZDMzFXdTBxcjAyZUxRMDRCZzd5WHlGYVdnR0NnUVBBcnJTZUptbm9jSWdJWG14YWUyaVFHM0tOc3dyYXFPU1g1YllpUWhlUDV1QThBdkRTYkdEcWQ2a09RYzNNdDZTeDZzRXVSYlk3QTRaa1hCR256bm5IWVY3c2VUbi02UXZNMFUxajlCMEFxamNYLU9zWkk1Wk1IcVNHRjJabXFkdE5NcjJwLWtyM2xGNS1vN25SRQ?oc=5", "source_name": "BioWorld News", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 54, "total_relevant": 2, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 2, "score": 50, "total": 2, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "earnings", "primary_label": "Earnings", "confidence": 58, "events": [{"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}, {"event": "general", "label": "Market update", "weight": 0.55, "count": 1}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 41.59, "latest_week": "2026-07-17", "one_week_move": -18.0, "four_week_move": -25.4, "twelve_week_move": -27.2, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.115378, "market_dynamics_buy_signal": false, "relative_strength": -25.899154, "fair_value_gap": -21.9, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "undecided", "expectation_probability": 51.1597, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-18.0% over one week, -25.4% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 50, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Earnings", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingView", "count": 1}, {"label": "BioWorld News", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 2}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Earnings", "count": 1}, {"label": "Market update", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Earnings", "tone": "neutral", "text": "58/100 classification confidence."}, {"label": "Company focus", "value": "2", "tone": "neutral", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-18.0% over one week, -25.4% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Price to earnings forward of Hangzhou Bio-Sincerity Pharma-Tech Co., Ltd. Class A \u2013 SZSE:301096"}], "updated_at": "2026-07-24T15:44:41.609444+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}